The renewal of the approval of microbial substance Purpureocillium lilacinum strain 251 was published in the Official Journal on 10.01.2022.
On 05.10.2021 the agenda for the upcoming SCoPAFF Legislation meeting of 21-22.10.2021 was published.
On 16.09.2021 the summary report/minutes of the SCoPAFF Legislation meeting of 05-06.07.2021 were published on the DG SANTE website.
The Polish competent authority published its report of the SCoPAFF Legislation meeting of 05-06.07.2021.
DG SANTE published the agenda for the upcoming SCoPAFF Legislation meeting on 5-6July.
On 07.05.2020 the extension of 44 substances was published in the Official Journal.
The agenda for the SCoPAFF Legislation meeting of 19-20.05.2021 is published on the SANTE website.
DG SANTE published the summary report of the 25-26 January meeting.
The agenda for the upcoming SCoPAFF Legislation meeting was published on the Commission website.
On 04.03.2021 DG SANTE published the short report on the SCoPAFF Legislation meeting of 22-23.10.2020.
On 06.01.2021, the agenda for the upcoming SCoPAFF Legislation meeting of 25-26.01.2021 was published.
On 16.11.2020 the agenda for the SCoPAFF Legislation meeting of 3-4 December was published.
The agenda for the SCoPAFF Legislation meeting of 22-23.10.2020 was published on 06.10.2020
Purpureocillium lilacinum strain 251, fludioxonil, Trichoderma harzianum T78
On 17.09.2020 EFSA published its conclusion on the peer review of Purpureocilium lilacinum strain 251.
Purpureocillium lilacinum strain 251
on 25.06.2020 a Regulation was published, extending the approval periods of 26 substances.
On 18.09.2018 EFSA initiated the public consultation on the RAR of Purpureocillium lilacinum strain 251.